title: WT1 and Pax2 re-expression is required for epithelial-mesenchymal transition in 5/6 nephrectomized rats and cultured kidney tubular epithelial cells.
abstract: Mature tubular epithelial cells in the adult kidney can undergo epithelial-mesenchymal transition (EMT), a phenotypic change that is linked to the pathogenesis of renal interstitial fibrosis. EMT may be considered the reverse of mesenchymal-epithelial transition, which occurs during normal kidney development. The Wilms' tumor suppressor gene WT1 and the paired box 2 gene Pax2 are needed to induce mesenchymal-epithelial transition and play key roles in the progression of nephrogenesis. However, until now, WT1 and Pax2 have not been tested for their direct involvement in the process of renal tubular EMT. In this study, we explored the potential roles of WT1 and Pax2 in EMT that is induced in the remnant kidney of rats following 5/6 nephrectomy. We also examined WT1 and Pax2 in cultured renal tubular epithelial (NRK52E) cells treated with interleukin-1α and investigated the effects of blocking EMT using RNA interference. We showed that WT1 and Pax2 were re-expressed in the EMT models, and these were accompanied by decreased expression of E-cadherin and increased expression of vimentin, Snail and α-smooth muscle actin. Silencing WT1 and Pax2 by RNA interference blocked the interleukin-1α-induced EMT in the NRK52E cells, as reflected in the suppression of α-SMA and Snail expression, the restoration of E-cadherin expression and normal cell morphology. Our experiments suggested that the re-expression of WT1 and Pax2 in the tubular epithelial cells plays important roles in the promotion of EMT, and there may be therapeutic value in silencing Pax2 and WT1 to prevent or reverse renal fibrosis.
authors.affiliation: Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
authors.forename: Bin
authors.initials: B
authors.lastname: Huang
authors.forename: Lei
authors.initials: L
authors.lastname: Pi
authors.forename: Cha
authors.initials: C
authors.lastname: Chen
authors.forename: Fei
authors.initials: F
authors.lastname: Yuan
authors.forename: Qingsong
authors.initials: Q
authors.lastname: Zhou
authors.forename: Junqi
authors.initials: J
authors.lastname: Teng
authors.forename: Tang
authors.initials: T
authors.lastname: Jiang
mesh_terms: D000818:Animals; D048430:Cell Shape / Q000187:drug effects; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism*; D058750:Epithelial-Mesenchymal Transition / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects / Q000473:pathology; D005355:Fibrosis; D020868:Gene Silencing / Q000187:drug effects; D053582:Interleukin-1alpha / Q000494:pharmacology; D007684:Kidney Tubules / Q000473:pathology* / Q000601:surgery*; D008297:Male; D009392:Nephrectomy; D051762:PAX2 Transcription Factor / Q000378:metabolism*; D034741:RNA, Small Interfering / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D025721:WT1 Proteins / Q000378:metabolism*
chemical_list: D053582:Interleukin-1alpha; D051762:PAX2 Transcription Factor; C551986:PAX2 protein, rat; D034741:RNA, Small Interfering; D025721:WT1 Proteins